# Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec

> **NCT02153346** · NA · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 101 (actual)

## Conditions studied

- Asthma

## Interventions

- **OTHER:** Valuation of lost productivity questionnaire
- **OTHER:** Work productivity and activity impairment questionnaire

## Key facts

- **NCT ID:** NCT02153346
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06-22
- **Primary completion:** 2016-04-01
- **Final completion:** 2016-04-22
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153346, "Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02153346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*